Maybe It'll Grow Hair...

Published Online: Saturday, June 1, 2002

Like Murphy?s Law, the Law of Unintended Consequences is rarely a good thing. Sometimes, however, compounds developed to treat a certain condition turn out to have completely unforeseen positive effects on other conditions. Certainly nobody suspected when it was developed that the blood pressure medicine minoxidil would have a second, more famous life as an OTC hair regrowth product.

Now, the same transformation may be happening with sulfasalazine, a drug often prescribed for psoriasis and RA. A team of researchers led by Charles N. Ellis, MD, of the University of Michi-gan in Ann Arbor has shown that sul-fasalazine can also help people with alopecia areata, a condition characterized by recurrent episodes of patchy hair loss.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues